UBS Group’s ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN CEFD Stock Holding History

UBS Group’s Portfolio CEFD Stock Details CEFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Buy	85,574 +6,293	+8%	+$119K	﹤0.01%	5221
2025 Q4	$1.52M	Buy	+79,281	New	+$1.53M	﹤0.01%	5202
2025 Q1	–	Sell	-79	Closed	-$1.55K	–	10267
2024 Q4	$1.55K	Buy	+79	New	+$1.6K	﹤0.01%	9209
2023 Q4	–	Sell	-812	Closed	-$14.4K	–	9354
2023 Q3	$14.4K	Buy	+812	New	+$15.4K	﹤0.01%	6956
2022 Q3	–	Sell	-546	Closed	-$12K	–	10384
2022 Q2	$12K	Buy	+546	New	+$13.2K	﹤0.01%	7639

UBS Group's CEFD Position: Q1 2026 in Review

UBS Group increased its ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN (CEFD) stake by 7.9% in Q1 2026, buying an estimated $119K and bringing the position to 85,574 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #5221.

UBS Group first reported a position in CEFD in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.52M in Q4 2025. 1 fund tracked by Wall St. Rank holds CEFD as of Q1 2026.

UBS Group held 85,574 shares of ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN worth $1.5M as of Q1 2026.
UBS Group bought 6,293 ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN shares in Q1 2026, an estimated $119K.
ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5221 holding.
UBS Group first reported a position in ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN in Q2 2022 and has held it in 5 quarters since.
UBS Group's ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN position peaked at $1.52M in Q4 2025.
1 fund tracked by Wall St. Rank held ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.